SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001171843-18-006662
Filing Date
2018-09-21
Accepted
2018-09-21 16:18:01
Documents
4
Effectiveness Date
2018-09-21

Document Format Files

Seq Description Document Type Size
1 FORM S-8 s8_092118.htm S-8 58863
2 EXHIBIT 5.1 exh_51.htm EX-5.1 4436
3 EXHIBIT 23.1 exh_231.htm EX-23.1 6089
4 GRAPHIC kpmg.jpg GRAPHIC 3402
  Complete submission text file 0001171843-18-006662.txt   75197
Mailing Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3
Business Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3 450-686-4555
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: S-8 | Act: 33 | File No.: 333-227476 | Film No.: 181081769
SIC: 2834 Pharmaceutical Preparations